Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.

Jabbour E, Kantarjian HM, Koller C, Taher A.

Cancer. 2008 Mar 1;112(5):1089-95. doi: 10.1002/cncr.23280. Review.

2.

Myelodysplastic syndromes and the role of iron overload.

Harvey RD.

Am J Health Syst Pharm. 2010 Apr;67(7 Suppl 2):S3-9. doi: 10.2146/ajhp090645.

PMID:
20332503
3.

Iron overload in myelodysplastic syndromes: diagnosis and management.

List AF.

Cancer Control. 2010 Jan;17 Suppl:2-8. Review.

PMID:
20125080
4.

Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.

Delforge M, Selleslag D, Triffet A, Mineur P, Bries G, Graux C, Trullemans F, MacDonald K, Abraham I, Pluymers W, Ravoet C.

Ann Hematol. 2011 Jun;90(6):655-66. doi: 10.1007/s00277-011-1164-9. Epub 2011 Feb 12.

PMID:
21318574
5.

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.

Gattermann N.

Int J Hematol. 2008 Jul;88(1):24-9. doi: 10.1007/s12185-008-0118-z. Epub 2008 Jun 27. Review.

6.

Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.

Malcovati L.

Clin Lymphoma Myeloma. 2009;9 Suppl 3:S305-11. doi: 10.3816/CLM.2009.s.029. Review.

PMID:
19778858
7.

Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.

Raptis A, Duh MS, Wang ST, Dial E, Fanourgiakis I, Fortner B, Paley C, Mody-Patel N, Corral M, Scott J.

Transfusion. 2010 Jan;50(1):190-9. doi: 10.1111/j.1537-2995.2009.02361.x. Epub 2009 Aug 28.

PMID:
19719471
8.

The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.

Platzbecker U, Hofbauer LC, Ehninger G, Hölig K.

Leuk Res. 2012 May;36(5):525-36. doi: 10.1016/j.leukres.2012.01.006. Epub 2012 Feb 1. Review.

PMID:
22300879
9.

The deleterious effects of iron overload in patients with myelodysplastic syndromes.

Dreyfus F.

Blood Rev. 2008 Dec;22 Suppl 2:S29-34. doi: 10.1016/S0268-960X(08)70006-7. Review.

PMID:
19059054
10.

Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform.

Valent P, Krieger O, Stauder R, Wimazal F, Nösslinger T, Sperr WR, Sill H, Bettelheim P, Pfeilstöcker M.

Eur J Clin Invest. 2008 Mar;38(3):143-9. doi: 10.1111/j.1365-2362.2007.01915.x. Epub 2008 Jan 24.

11.

Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox.

Kikuchi S, Kobune M, Iyama S, Sato T, Murase K, Kawano Y, Takada K, Ono K, Kaneko Y, Miyanishi K, Sato Y, Hayashi T, Takimoto R, Kato J.

Free Radic Biol Med. 2012 Aug 15;53(4):643-8. doi: 10.1016/j.freeradbiomed.2012.06.006. Epub 2012 Jun 15.

PMID:
22705364
12.

Impact of iron overload in myelodysplastic syndromes.

Fenaux P, Rose C.

Blood Rev. 2009 Dec;23 Suppl 1:S15-9. doi: 10.1016/S0268-960X(09)70005-0. Review.

PMID:
20116635
13.

[Iron overload and myelodysplastic syndromes].

Rose C, Cambier N, Mahieu M, Ernst O, Fenaux P.

Transfus Clin Biol. 2001 Oct;8(5):422-32. Review. French.

PMID:
11729396
14.

Iron overload in myelodysplastic syndromes.

Mahesh S, Ginzburg Y, Verma A.

Leuk Lymphoma. 2008 Mar;49(3):427-38. doi: 10.1080/10428190701843221. Review.

PMID:
18297518
15.
16.
17.

Iron overload in MDS-pathophysiology, diagnosis, and complications.

Gattermann N, Rachmilewitz EA.

Ann Hematol. 2011 Jan;90(1):1-10. doi: 10.1007/s00277-010-1091-1. Epub 2010 Oct 12. Review.

PMID:
20938663
18.

Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.

Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T, Thomas PW, Killick SB.

Br J Haematol. 2007 Sep;138(5):587-93. Epub 2007 Jul 4.

PMID:
17610536
19.

Consensus statement on iron overload in myelodysplastic syndromes.

Bennett JM; MDS Foundation's Working Group on Transfusional Iron Overload.

Am J Hematol. 2008 Nov;83(11):858-61. doi: 10.1002/ajh.21269.

20.

Supplemental Content

Support Center